Cellectis SA (CLLS)
2.51
-0.06
(-2.33%)
USD |
NASDAQ |
Jun 10, 14:41
Cellectis Cash and Short Term Investments (Quarterly): 149.17M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 149.17M |
| December 31, 2023 | 203.82M |
| September 30, 2023 | 67.36M |
| June 30, 2023 | 85.51M |
| March 31, 2023 | 88.16M |
| December 31, 2022 | 97.70M |
| September 30, 2022 | 119.01M |
| June 30, 2022 | 129.44M |
| March 31, 2022 | 154.87M |
| December 31, 2021 | 186.14M |
| September 30, 2021 | 211.10M |
| June 30, 2021 | 251.62M |
| March 31, 2021 | 225.90M |
| December 31, 2020 | 268.24M |
| September 30, 2020 | 302.18M |
| June 30, 2020 | 311.09M |
| March 31, 2020 | 346.14M |
| December 31, 2019 | 360.91M |
| September 30, 2019 | 362.87M |
| June 30, 2019 | 397.36M |
| March 31, 2019 | 421.84M |
| December 31, 2018 | 451.89M |
| September 30, 2018 | 475.91M |
| June 30, 2018 | 491.09M |
| March 31, 2018 | 282.06M |
| Date | Value |
|---|---|
| December 31, 2017 | 296.98M |
| September 30, 2017 | 304.10M |
| June 30, 2017 | 271.82M |
| March 31, 2017 | 276.27M |
| December 31, 2016 | 291.16M |
| September 30, 2016 | 296.14M |
| June 30, 2016 | 300.02M |
| March 31, 2016 | 313.38M |
| December 31, 2015 | 343.56M |
| September 30, 2015 | 314.33M |
| June 30, 2015 | 318.41M |
| March 31, 2015 | 128.20M |
| December 31, 2014 | 136.62M |
| June 30, 2014 | 27.58M |
| December 31, 2013 | 10.44M |
| June 30, 2013 | 12.42M |
| June 30, 2013 | 12.42M |
| December 31, 2012 | 28.84M |
| June 30, 2012 | 35.24M |
| December 31, 2011 | 54.93M |
| December 31, 2010 | 31.98M |
| June 30, 2010 | 46.51M |
| June 30, 2010 | 46.51M |
| December 31, 2009 | 64.59M |
| June 30, 2009 | 37.98M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
67.36M
Minimum
Sep 2023
397.36M
Maximum
Jun 2019
215.93M
Average
207.46M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Edap TMS SA | 41.51M |
| DBV Technologies SA | 101.52M |
| Genfit SA | 85.99M |
| Biophytis SA | 6.560M |
| Adaptimmune Therapeutics PLC | 143.65M |